4.5 Article

Human neutrophils are activated by a peptide fragment of Clostridium difficile toxin B presumably via formyl peptide receptor

期刊

CELLULAR MICROBIOLOGY
卷 17, 期 6, 页码 893-909

出版社

WILEY
DOI: 10.1111/cmi.12410

关键词

-

资金

  1. Niedersachsen Vorab [VWZN2889]
  2. CDiff project [TP5]
  3. Deutsche Forschungsgemeinschaft [SFB621]

向作者/读者索取更多资源

Clostridium difficile may induce antibiotic-associated diarrhoea and, in severe cases, pseudomembranous colitis characterized by tremendous neutrophil infiltration. All symptoms are caused by two exotoxins: TcdA and TcdB. We describe here the activation of isolated human blood neutrophils by TcdB and, moreover, by toxin fragments generated by limited proteolytical digestion. Kinetics and profiles of TcdB-induced rise in intracellular-free Ca2+ and reactive oxygen species production were similar to that induced by fMLF, which activates the formyl peptide receptor (FPR) recognizing formylated bacterial peptide sequences. Transfection assays with the FPR-1 isoform hFPR26 in HEK293 cells, heterologous desensitization experiments and FPR inhibition via cyclosporineH strongly suggest activation of cells via FPR-1. Domain analyses revealed that the N-terminal glucosyltransferase domain of TcdB is a potent activator of FPR pointing towards an additional mechanism that might contribute to pathogenesis. This pro-inflammatory ligand effect can be triggered even by cleaved and, thus, non-cytotoxic toxin. In summary, we report (i) a ligand effect on neutrophils as completely new molecular mode of action, (ii) pathogenic potential of truncated or proteolytically cleaved non-cytotoxic' fragments and (iii) an interaction of the N-terminal glucosyltransferase domain instead of the C-terminal receptor binding domain of TcdB with target cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

High constitutive Akt2 activity in U937 promonocytes: effective reduction of Akt2 phosphorylation by the histamine H2-receptor and the β2-adrenergic receptor

Kristin Werner, Detlef Neumann, Roland Seifert

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2016)

Article Pharmacology & Pharmacy

Lack of Histamine H4-Receptor Expression Aggravates TNBS-Induced Acute Colitis Symptoms in Mice

Eva J. Wunschel, Bastian Schirmer, Roland Seifert, Detlef Neumann

FRONTIERS IN PHARMACOLOGY (2017)

Article Pharmacology & Pharmacy

Mouse Colonic Epithelial Cells Functionally Express the Histamine H4 Receptor

Bastian Schirmer, Luisa Lindemann, Kaya Saskia Bittkau, Rukijat Isaev, Daniela Boesche, Malte Juchem, Roland Seifert, Detlef Neumann

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)

Article Geriatrics & Gerontology

Interleukin-4 administration improves muscle function, adult myogenesis, and lifespan of colon carcinoma-bearing mice

Domiziana Costamagna, Robin Duelen, Fabio Penna, Detlef Neumann, Paola Costelli, Maurilio Sampaolesi

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)

Article Oncology

Genetic Deficiency of the Histamine H4-Receptor Reduces Experimental Colorectal Carcinogenesis in Mice

Bastian Schirmer, Tamina Rother, Inga Bruesch, Andre Bleich, Christopher Werlein, Danny Jonigk, Roland Seifert, Detlef Neumann

CANCERS (2020)

Review Biochemistry & Molecular Biology

The Function of the Histamine H4 Receptor in Inflammatory and Inflammation-Associated Diseases of the Gut

Bastian Schirmer, Detlef Neumann

Summary: Histamine is a versatile mediator involved in various physiological processes, including the regulation of inflammation. Approved compounds targeting histamine receptors are used for allergic inflammation, gastric acid reduction, and narcolepsy treatment. H4R ligands are still under investigation for inflammatory diseases, showing moderate effects so far.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Editorial Material Pharmacology & Pharmacy

Probiotics in Naunyn-Schmiedeberg's Archives of Pharmacology

Detlef Neumann, Roland Seifert

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2021)

Article Pharmacology & Pharmacy

Histamine H1- and H4-receptor expression in human colon-derived cell lines

Jasper Carsten Schrammel, Martin Koenig, Miriam Frommer, Kaya Saskia Andersen, Marla Kirsten, Roland Seifert, Detlef Neumann, Bastian Schirmer

Summary: By studying cell lines, it was found that colon epithelial cells have functional expression of H4 receptors, which further confirmed the involvement of H4 receptors in inflammatory bowel disease and associated colon cancer. However, the transferability of these data to humans is uncertain. The expression of histamine receptor subtypes varied among different cell lines, and genetic modification is necessary for detailed functional analysis in human colon-derived cell lines.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2023)

Meeting Abstract Cell Biology

LACK OF HISTAMINE H4-RECEPTOR EXPRESSION PROTECTS MICE FROM CHEMICALLY INDUCED INFLAMMATION ASSOCIATED WITH COLON CARCINOMA

T. Rother, B. Schirmer, R. Seifert, D. Neumann

INFLAMMATION RESEARCH (2019)

Meeting Abstract Pharmacology & Pharmacy

Evidence for the involvement of histamine H4-receptor function in the pathogenesis of experimental inflammation-associated colorectal carcinoma

T. Rother, B. Schirmer, R. Seifert, D. Neumann

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2019)

Meeting Abstract Pharmacology & Pharmacy

Is the histamine H4-receptor a useful pharmacologic target in colitis?

D. Neumann, E. Wunschel, B. Schirmer

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2017)

Meeting Abstract Pharmacology & Pharmacy

No evidence for a role of the histamine H4-receptor in chronic DSS induced colitis

B. Schirmer, T. Rezniczek, R. Seifert, D. Neumann

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2016)

Meeting Abstract Pharmacology & Pharmacy

The histamine H-4-receptor affects experimental colitis due to its functional expression on epithelial cells of the mouse colon

K. Bittkau, L. Bringmann, D. Boesche, R. Isaev, B. Schirmer, R. Seifert, D. Neumann

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2018)

暂无数据